ChromaDex® Corp. (OTCQB: CDXC) ("ChromaDex") an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, animal health, cosmetic and pharmaceutical industries, announced today it has signed a distribution agreement with IsoLife bv, which provides stable isotope labeled phytochemicals and plant products. These 13C- and 15N-labeled phytochemicals and plant products are used as tracers and internal standards for food & beverage, nutraceutical, pharmaceutical, cosmeceutical and environmental sciences research.
"The IsoLife agreement will add to ChromaDex's comprehensive and growing catalog, which contains more than 3,000 phytochemicals and 500 botanical reference materials," said Frank Jaksch , CEO and co-founder of ChromaDex. "By adding the IsoLife stable isotope materials to our portfolio, we continue our commitment to providing access to key materials to the research community, helping to facilitate important research for the Life Science industry."
Ton Gorissen and Ries de Visser, directors and founders of IsoLife, note the co-operation with ChromaDex is a natural extension of IsoLife's activities. "By using the excellent sales force of ChromaDex, we will be much better able to serve Life Science research needs in the overseas markets. The non-labeled and stable isotope-labeled products of both companies perfectly match and complement each other."